Quick Answer
Silo Pharma, Inc. reported Operating Income of -$4.28 million for fiscal year 2025.
Silo Pharma, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$4.28M | +9.0% |
| 2024 | -$4.71M | -22.0% |
| 2023 | -$3.86M | -6.3% |
| 2022 | -$3.63M | -32.2% |
| 2021 | -$2.74M | -24.6% |
| 2020 | -$2.20M | -136.6% |
| 2019 | -$930.4K | -56.6% |
| 2018 | -$594.2K | -21.1% |
| 2017 | -$490.9K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.15M | -14.0% | +7.8% |
| June 30, 2025 | -$1.25M | -24.5% | -14.1% |
| March 31, 2025 | -$1.09M | -24.4% | -8.3% |
| September 30, 2024 | -$1.01M | -30.6% | -0.7% |
| June 30, 2024 | -$1.00M | +10.1% | -14.0% |
| March 31, 2024 | -$879.5K | -9.5% | -13.7% |
| September 30, 2023 | -$773.4K | +18.5% | +30.6% |
| June 30, 2023 | -$1.11M | -125.6% | -38.8% |
- Silo Pharma, Inc. showed an increase of +9.0% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, Silo Pharma, Inc.’s operating income has declined by 772.1% (from -$490.9 thousand to -$4.28 million).
- The most recent figure is from Silo Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: